PRIMARY IMMUNODEFICIENCY DISEASES (PID)
Clinical trials for PRIMARY IMMUNODEFICIENCY DISEASES (PID) explained in plain language.
Never miss a new study
Get alerted when new PRIMARY IMMUNODEFICIENCY DISEASES (PID) trials appear
Sign up with your email to follow new studies for PRIMARY IMMUNODEFICIENCY DISEASES (PID), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immune drug tested Head-to-Head against standard treatment
Disease control CompletedThis study tested a new treatment called TAK-881 for people with primary immunodeficiency, a condition where the body's immune system doesn't work properly. It directly compared TAK-881 to an existing treatment, HYQVIA, in adults and teenagers, while also testing TAK-881 alone in…
Matched conditions: PRIMARY IMMUNODEFICIENCY DISEASES (PID)
Phase: PHASE2, PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Three-year safety check for immune disease treatment continues
Disease control CompletedThis study followed 15 Japanese patients with primary immunodeficiency diseases for 3 years to check long-term side effects of TAK-771 injections. Participants had already completed a previous study and received regular injections during clinic visits. The main goal was to monito…
Matched conditions: PRIMARY IMMUNODEFICIENCY DISEASES (PID)
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC